Atlas Trials

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Clinical trial NCT05661266 · COMPLETED

Trial details

NCT number
NCT05661266
Sponsor
Innodem Neurosciences
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2023-08-16
Primary completion
2025-04-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.